Drug intelligence / Profile preview

TheraTears Liquid Gel

Development stage
Unknown
Lead developer
Prestige Consumer Healthcare
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

TheraTears Liquid Gel (also marketed as TheraTears Liquid Gel Nighttime Dry Eye Therapy) is an over-the-counter, preservative-free, hypotonic, electrolyte-balanced lubricant eye gel. It contains 1% sodium carboxymethylcellulose (CMC) as its active ingredient, which is a viscous polymer that acts as an ocular lubricant and demulcent to protect and soothe the ocular surface. Formulated to mimic the natural composition of healthy tears, it contains five vital electrolytes (OxyLytes) to correct the salt imbalance associated with dry eye symptoms. It is indicated for the temporary relief of dry eye symptoms, including burning, irritation, and discomfort. In clinical research, such as studies led by Ms. Kuan-Li Lily Ho, it has been evaluated in adult orthokeratology lens wearers to assess its effects on anterior eye health, comfort, refraction, and visual acuity.

Brand names
TheraTears Liquid GelTheraTears Liquid Gel Nighttime Dry Eye Therapy
Other names
sodium carboxymethylcellulose 1% ophthalmic gelcarboxymethylcellulose sodium 1% gel
02

Targets

Extracellular matrix proteins on the corneal surface

Beyond the preview

Go deeper on TheraTears Liquid Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheraTears Liquid Gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call